{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["AP1", "Apoptosis", "Cholesterol biosynthesis", "Drug screening", "ERK1/2 agonist compounds", "Leukemia inhibition", "SREBP1/2"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34107900", "DateCompleted": {"Year": "2021", "Month": "11", "Day": "02"}, "DateRevised": {"Year": "2021", "Month": "11", "Day": "02"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "06", "Day": "09"}], "Language": ["eng"], "ELocationID": ["680", "10.1186/s12885-021-08402-6"], "Journal": {"ISSN": "1471-2407", "JournalIssue": {"Volume": "21", "Issue": "1", "PubDate": {"Year": "2021", "Month": "Jun", "Day": "09"}}, "Title": "BMC cancer", "ISOAbbreviation": "BMC Cancer"}, "ArticleTitle": "ERK activation via A1542/3 limonoids attenuates erythroleukemia through transcriptional stimulation of cholesterol biosynthesis genes.", "Pagination": {"StartPage": "680", "MedlinePgn": "680"}, "Abstract": {"AbstractText": ["Cholesterol plays vital roles in human physiology; abnormal levels have deleterious pathological consequences. In cancer, elevated or reduced expression of cholesterol biosynthesis is associated with good or poor prognosis, but the underlying mechanisms are largely unknown. The limonoid compounds A1542 and A1543 stimulate ERK/MAPK by direct binding, leading to leukemic cell death and suppression of leukemia in mouse models. In this study, we investigated the downstream consequences of these ERK/MAPK agonists in leukemic cells.", "We employed RNAseq analysis combined with Q-RT-PCR, western blot and bioinformatics to identify and confirm genes whose expression was altered by A1542 and A1543 in leukemic cells. ShRNA lentiviruses were used to silence gene expression. Cell culture and an animal model (BALB/c) of erythroleukemia induced by Friend virus were utilized to validate effects of cholesterol on leukemia progression.", "RNAseq analysis of A1542-treated cells revealed the induction of all 18 genes implicated in cholesterol biosynthesis. Expression of these cholesterol genes was blocked by cedrelone, an ERK inhibitor. The cholesterol inhibitor lovastatin diminished ERK/MAPK activation by A1542, thereby reducing leukemic cell death induced by this ERK1/2 agonist. Growth inhibition by cholesterol was observed both at the intracellular level, and when orally administrated into a leukemic mouse model. Both HDL and LDL also suppressed leukemogenesis, implicating these lipids as important prognostic markers for leukemia progression. Mechanistically, knockdown experiments revealed that the activation of SREBP1/2 by A1542-A1543 was responsible for induction of only a sub-set of cholesterol biosynthesis genes. Induction of other regulatory factors by A1542-A1543 including EGR1, AP1 (FOS\u2009+\u2009JUN) LDLR, IER2 and others may cooperate with SREBP1/2 to induce cholesterol genes. Indeed, pharmacological inhibition of AP1 significantly inhibited cholesterol gene expression induced by A1542. In addition to leukemia, high expression of cholesterol biosynthesis genes was found to correlate with better prognosis in renal cancer.", "This study demonstrates that ERK1/2 agonists suppress leukemia and possibly other types of cancer through transcriptional stimulation of cholesterol biosynthesis genes."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Province Science City, High Tech Zone, Baiyun District, Guiyang, 550014, Guizhou Province, People's Republic of China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academic of Sciences, Guiyang, 550014, Guizhou Province, People's Republic of China."}], "LastName": "Yu", "ForeName": "Fang", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Province Science City, High Tech Zone, Baiyun District, Guiyang, 550014, Guizhou Province, People's Republic of China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academic of Sciences, Guiyang, 550014, Guizhou Province, People's Republic of China."}, {"Identifier": [], "Affiliation": "School of Pharmaceutical Sciences, Guizhou Medical University, Guiyang, 550025, Guizhou Province, People's Republic of China."}], "LastName": "Gajendran", "ForeName": "Babu", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Province Science City, High Tech Zone, Baiyun District, Guiyang, 550014, Guizhou Province, People's Republic of China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academic of Sciences, Guiyang, 550014, Guizhou Province, People's Republic of China."}], "LastName": "Wang", "ForeName": "Ning", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The National Health Commission's Key Laboratory of Immunological Pulmonary Disease, Guizhou Provincial People's Hospital, The Affiliated Hospital of Guizhou University, Guiyang, 550002, Guizhou Province, People's Republic of China."}], "LastName": "Sample", "ForeName": "Klarke M", "Initials": "KM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Province Science City, High Tech Zone, Baiyun District, Guiyang, 550014, Guizhou Province, People's Republic of China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academic of Sciences, Guiyang, 550014, Guizhou Province, People's Republic of China."}], "LastName": "Liu", "ForeName": "Wuling", "Initials": "W"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Province Science City, High Tech Zone, Baiyun District, Guiyang, 550014, Guizhou Province, People's Republic of China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academic of Sciences, Guiyang, 550014, Guizhou Province, People's Republic of China."}], "LastName": "Wang", "ForeName": "Chunlin", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Province Science City, High Tech Zone, Baiyun District, Guiyang, 550014, Guizhou Province, People's Republic of China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academic of Sciences, Guiyang, 550014, Guizhou Province, People's Republic of China."}], "LastName": "Hu", "ForeName": "Anling", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicine, University of Toronto, Toronto, Ontario, Canada."}, {"Identifier": [], "Affiliation": "Division of Advanced Diagnostics, Toronto General Research Institute-University Health Network, Toronto, Ontario, Canada."}], "LastName": "Zacksenhaus", "ForeName": "Eldad", "Initials": "E"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Province Science City, High Tech Zone, Baiyun District, Guiyang, 550014, Guizhou Province, People's Republic of China. haoxj@mail.kib.ac.cn."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academic of Sciences, Guiyang, 550014, Guizhou Province, People's Republic of China. haoxj@mail.kib.ac.cn."}], "LastName": "Hao", "ForeName": "Xiaojiang", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Province Science City, High Tech Zone, Baiyun District, Guiyang, 550014, Guizhou Province, People's Republic of China. yaacovbendavid@hotmail.com."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academic of Sciences, Guiyang, 550014, Guizhou Province, People's Republic of China. yaacovbendavid@hotmail.com."}], "LastName": "Ben-David", "ForeName": "Yaacov", "Initials": "Y"}], "GrantList": [{"GrantID": "21867009 and U1812403", "Agency": "National Natural Science Foundation of China", "Country": ""}, {"GrantID": "QKHPTRC[2019]5627", "Agency": "Guizhou Science and Technology Department", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "BMC Cancer", "NlmUniqueID": "100967800", "ISSNLinking": "1471-2407"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Limonins"}, {"RegistryNumber": "97C5T2UQ7J", "NameOfSubstance": "Cholesterol"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["metabolism"], "DescriptorName": "Cholesterol"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["genetics", "mortality"], "DescriptorName": "Leukemia"}, {"QualifierName": ["metabolism"], "DescriptorName": "Limonins"}, {"QualifierName": ["physiology"], "DescriptorName": "MAP Kinase Signaling System"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Signal Transduction"}, {"QualifierName": [], "DescriptorName": "Survival Analysis"}, {"QualifierName": [], "DescriptorName": "Transfection"}], "CoiStatement": "The authors declare no competing interests."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Ikonen E. Cellular cholesterol trafficking and compartmentalization. Nat Rev Mol Cell Biol. 2008;9(2):125\u2013138. doi: 10.1038/nrm2336.", "ArticleIdList": ["10.1038/nrm2336", "18216769"]}, {"Citation": "Smith B, Land H. Anticancer activity of the cholesterol exporter ABCA1 gene. Cell Rep. 2012;2(3):580\u2013590. doi: 10.1016/j.celrep.2012.08.011.", "ArticleIdList": ["10.1016/j.celrep.2012.08.011", "PMC3462268", "22981231"]}, {"Citation": "Krycer JR, Brown AJ. Cholesterol accumulation in prostate cancer: a classic observation from a modern perspective. Biochim Biophys Acta. 1835;2013:219\u2013229.", "ArticleIdList": ["23357067"]}, {"Citation": "Shafique K, McLoone P, Qureshi K, Leung H, Hart C, Morrison DS. Cholesterol and the risk of grade-specific prostate cancer incidence: evidence from two large prospective cohort studies with up to 37 years' follow up. BMC Cancer. 2012;12(1):25. doi: 10.1186/1471-2407-12-25.", "ArticleIdList": ["10.1186/1471-2407-12-25", "PMC3271031", "22260413"]}, {"Citation": "Pelton K, Freeman MR, Solomon KR. Cholesterol and prostate cancer. Curr Opin Pharmacol. 2012;12(6):751\u2013759. doi: 10.1016/j.coph.2012.07.006.", "ArticleIdList": ["10.1016/j.coph.2012.07.006", "PMC3515742", "22824430"]}, {"Citation": "Allott EH, Howard LE, Cooperberg MR, Kane CJ, Aronson WJ, Terris MK, Amling CL, Freedland SJ. Serum lipid profile and risk of prostate cancer recurrence: results from the SEARCH database. Cancer Epidemiol Biomark Prev. 2014;23(11):2349\u20132356. doi: 10.1158/1055-9965.EPI-14-0458.", "ArticleIdList": ["10.1158/1055-9965.EPI-14-0458", "PMC4221498", "25304929"]}, {"Citation": "Kuzu OF. Noory MA, Robertson GP. The role of cholesterol in cancer. Cancer Res. 2016;76(8):2063\u20132070. doi: 10.1158/0008-5472.CAN-15-2613.", "ArticleIdList": ["10.1158/0008-5472.CAN-15-2613", "PMC5813477", "27197250"]}, {"Citation": "Nielsen SF, Nordestgaard BG, Bojesen SE. Statin use and reduced cancer related mortality. N Engl J Med. 2012;367(19):1792\u20131802. doi: 10.1056/NEJMoa1201735.", "ArticleIdList": ["10.1056/NEJMoa1201735", "23134381"]}, {"Citation": "Ravnskov U, Rosch PJ, McCully KS. Statins do not protect against cancer: quite the opposite. J Clin Oncol. 2015;33(7):810\u2013811. doi: 10.1200/JCO.2014.58.9564.", "ArticleIdList": ["10.1200/JCO.2014.58.9564", "25605834"]}, {"Citation": "Bjerre LM, LeLorier J. Do statins cause cancer? A meta-analysis of large randomized clinical trials. Am J Med. 2001;110(9):716\u2013723. doi: 10.1016/S0002-9343(01)00705-7.", "ArticleIdList": ["10.1016/S0002-9343(01)00705-7", "11403756"]}, {"Citation": "Pedersen TR, Wilhelmsen L, Faergeman O, Strandberg TE, Thorgeirsson G, Troedsson L, et al. Follow-up study of patients randomized in the Scandinavian simvastatin survival study (4S) of cholesterol lowering. Am J Cardiol. 2000;86(3):257\u2013262. doi: 10.1016/S0002-9149(00)00910-3.", "ArticleIdList": ["10.1016/S0002-9149(00)00910-3", "10922429"]}, {"Citation": "Parsa N, Taravatmanesh S, Trevisan M. Is low cholesterol a risk factor for cancer mortality? Eur J Cancer Prev. 2018;27(6):570\u2013576. doi: 10.1097/CEJ.0000000000000391.", "ArticleIdList": ["10.1097/CEJ.0000000000000391", "28683011"]}, {"Citation": "Kitahara CM, de Gonz\u00e1lez AB, Freedman ND, Huxley R, Mok Y, Jee SH, Samet JM. Total cholesterol and cancer risk in a large prospective study in Korea. J Clin Oncol. 2011;29(12):1592\u20131598. doi: 10.1200/JCO.2010.31.5200.", "ArticleIdList": ["10.1200/JCO.2010.31.5200", "PMC3082977", "21422422"]}, {"Citation": "Wang Y, Wang ZQ, Wang FH, Lei XF, Yan SM, Wang DS, Zhang F, Xu RH, Wang LY, Li YH. Predictive value of chemotherapy-related high-density lipoprotein cholesterol (HDL) elevation in patients with colorectal cancer receiving adjuvant chemotherapy: an exploratory analysis of 851 cases. Oncotarget. 2016;7(35):57290\u201357300. doi: 10.18632/oncotarget.10145.", "ArticleIdList": ["10.18632/oncotarget.10145", "PMC5302989", "27344180"]}, {"Citation": "Freed-Pastor WA, Mizuno H, Zhao X, Langerod a, moon SH, Rodriguez-Barrueco R, Barsotti a, Chicas a, Li W, Polotskaia a, Bissell MJ, Osborne TF, Tian B, Lowe SW, Silva JM, B\u00f8rresen-dale AL, Aj L, Bargonetti J, Prives C. Mutant p53 disrupts mammary tissue architecture via the mevalonate pathway. Cell. 2012;148(1-2):244\u2013258. doi: 10.1016/j.cell.2011.12.017.", "ArticleIdList": ["10.1016/j.cell.2011.12.017", "PMC3511889", "22265415"]}, {"Citation": "Sorrentino G, Ruggeri N, Specchia V, Cordenonsi M, Mano M, Dupont S, Manfrin A, Ingallina E, Sommaggio R, Piazza S, Rosato A, Piccolo S, Sal GD. Metabolic control of YAP and TAZ by the mevalonate pathway. Nat Cell Biol. 2014;16(4):357\u2013366. doi: 10.1038/ncb2936.", "ArticleIdList": ["10.1038/ncb2936", "24658687"]}, {"Citation": "Epand RM. Cholesterol and the interaction of proteins with membrane domains. Prog Lipid Res. 2006;45(4):279\u2013294. doi: 10.1016/j.plipres.2006.02.001.", "ArticleIdList": ["10.1016/j.plipres.2006.02.001", "16574236"]}, {"Citation": "Goldstein JL, DeBose-Boyd RA, Brown MS. Protein sensors for membrane sterols. Cell. 2006;124(1):35\u201346. doi: 10.1016/j.cell.2005.12.022.", "ArticleIdList": ["10.1016/j.cell.2005.12.022", "16413480"]}, {"Citation": "Vergnes L, Chin RG, de Aguiar VT, Fong LG, Osborne TF, Young SG, Reue K. SREBP-2-deficient and hypomorphic mice reveal roles for SREBP-2 in embryonic development and SREBP-1c expression. J Lipid Res. 2016;57(3):410\u2013421. doi: 10.1194/jlr.M064022.", "ArticleIdList": ["10.1194/jlr.M064022", "PMC4766990", "26685326"]}, {"Citation": "Gokey NG, Lopez-Anido C, Gillian-Danie AL, Svaren J. Early growth response 1 (Egr1) regulates cholesterol biosynthetic gene expression. J Biol Chem. 2011;286(34):29501\u201329510. doi: 10.1074/jbc.M111.263509.", "ArticleIdList": ["10.1074/jbc.M111.263509", "PMC3190990", "21712389"]}, {"Citation": "Keeton AB, Bortoff KD, Bennett WL, Franklin JL, Venable DY, Messina JL. Insulin-regulated expression of Egr-1 and Krox20: dependence on ERK1/2 and interaction with p38 and PI3-kinase pathways. Endocrinology. 2003;144(12):5402\u20135410. doi: 10.1210/en.2003-0592.", "ArticleIdList": ["10.1210/en.2003-0592", "12970165"]}, {"Citation": "Wang N, Fan Y, Yuan CM, Song J, Yao Y, Liu W, Gajendran B, Zacksenhaus E, Li Y, Liu J, Hao XJ, Ben-David Y. Selective ERK1/2 agonists isolated from Melia azedarach with potent anti-leukemic activity. BMC Cancer. 2019;19(1):764. doi: 10.1186/s12885-019-5914-8.", "ArticleIdList": ["10.1186/s12885-019-5914-8", "PMC6679490", "31375085"]}, {"Citation": "Ben-David Y, Giddens EB, Bernstein A. Identification and mapping of a common proviral integration site Fli-1 in erythroleukemia cells induced by friend murine leukemia virus. Proc Natl Acad Sci U S A. 1990;87(4):1332\u20131336. doi: 10.1073/pnas.87.4.1332.", "ArticleIdList": ["10.1073/pnas.87.4.1332", "PMC53469", "2304901"]}, {"Citation": "Liu T, Xia L, Yao Y, Yan C, Fan Y, Gajendran B, Yang J, Li YJ, Chen J, Filmus J, Spaner DE, Zacksenhaus E, Hao X, Ben-David Y. Identification of diterpenoid compounds that interfere with Fli-1 DNA binding to suppress leukemogenesis. Cell Death Dis. 2019;10(2):117. doi: 10.1038/s41419-019-1363-1.", "ArticleIdList": ["10.1038/s41419-019-1363-1", "PMC6370842", "30741932"]}, {"Citation": "Szklarczyk D, Gable AL, Lyon D, Junge A, Wyder S, Huerta-Cepas J, Simonovic M, Doncheva NT, Morris JH, Bork P, Jensen LJ, von Mering C. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019;47(D1):D607\u2013D613. doi: 10.1093/nar/gky1131.", "ArticleIdList": ["10.1093/nar/gky1131", "PMC6323986", "30476243"]}, {"Citation": "Ricketts CJ, De Cubas AA, Fan H, Smith CC, Lang M, Reznik E, Bowlby R, Gibb EA, Akbani R, Beroukhim R, Bottaro DP, Choueiri TK, Gibbs RA, Godwin AK, Haake S, Hakimi AA, Henske EP, Hsieh JJ, Ho TH, Kanchi RS, Krishnan B, Kwiatkowski DJ, Lui W, Merino MJ, Mills GB, Myers J, Nickerson ML, Reuter VE, Schmidt LS, Shelley CS, Shen H, Shuch B, Signoretti S, Srinivasan R, Tamboli P, Thomas G, Vincent BG, Vocke CD, Wheeler DA, Yang L, Kim WY, Robertson AG, Spellman PT, Rathmell WK, Linehan WM. The cancer genome atlas comprehensive molecular characterization of renal cell carcinoma. Cell Rep. 2018;23(1):313\u2013326.e5. doi: 10.1016/j.celrep.2018.03.075.", "ArticleIdList": ["10.1016/j.celrep.2018.03.075", "PMC6075733", "29617669"]}, {"Citation": "Uhlen M, Zhang C, Lee S, Sj\u00f6stedt E, Fagerberg L, Bidkhori G, Benfeitas R, Arif M, Liu Z, Edfors F, Sanli K, von Feilitzen K, Oksvold P, Lundberg E, Hober S, Nilsson P, Mattsson J, Schwenk JM, Brunnstr\u00f6m H, Glimelius B, Sj\u00f6blom T, Edqvist PH, Djureinovic D, Micke P, Lindskog C, Mardinoglu A, Ponten F. A pathology atlas of the human cancer transcriptome. Science. 2017;357(6352):eaan2507. doi: 10.1126/science.aan2507.", "ArticleIdList": ["10.1126/science.aan2507", "28818916"]}, {"Citation": "Cerezo-Guisado MI, Garc\u00eda-Rom\u00e1n N, Garc\u00eda-Mar\u00edn LJ, Alvarez-Barrientos A, Bragado MJ, Lorenzo MJ. Lovastatin inhibits the extracellular-signal-regulated kinase pathway in immortalized rat brain neuroblasts. Biochem J. 2007;401(1):175\u2013183. doi: 10.1042/BJ20060731.", "ArticleIdList": ["10.1042/BJ20060731", "PMC1698684", "16952276"]}, {"Citation": "Schonewille M, de Boer JF, Mele L, Wolters H, Bloks VW, Wolters JC, Kuivenhoven JA, Tietge UJ, Brufau G, Groen AK. Statins increase hepatic cholesterol synthesis and stimulate fecal cholesterol elimination in mice. J Lipid Res. 2016;57(8):1455\u20131464. doi: 10.1194/jlr.M067488.", "ArticleIdList": ["10.1194/jlr.M067488", "PMC4959861", "27313057"]}, {"Citation": "Howard JC, Yousefi S, Cheong G, Bernstein A, Ben-David Y. Temporal order and functional analysis of mutations within the Fli-1 and p53 genes during the erythroleukemias induced by F-MuLV. Oncogene. 1993;8(10):2721\u20132729.", "ArticleIdList": ["8378083"]}, {"Citation": "Plotnikov A, Zehorai E, Procaccia S, Seger R. The MAPK cascades: signaling components, nuclear roles and mechanisms of nuclear translocation. Biochim Biophys Acta. 2011;1813(9):1619\u20131633. doi: 10.1016/j.bbamcr.2010.12.012.", "ArticleIdList": ["10.1016/j.bbamcr.2010.12.012", "21167873"]}, {"Citation": "Braicu C, Buse M, Busuioc C, Drula R, Gulei D, Raduly L, Rusu A, Irimie A, Atanasov AG, Slaby O, Ionescu C, Berindan-Neagoe I. A comprehensive review on MAPK: a promising therapeutic target in cancer. Cancers (Basel) 2019;11(10):1618. doi: 10.3390/cancers11101618.", "ArticleIdList": ["10.3390/cancers11101618", "PMC6827047", "31652660"]}, {"Citation": "Bakiri L, Hamacher R, Gra\u00f1a O, Gu\u00edo-Carri\u00f3n A, Campos-Olivas R, Martinez L, Dienes HP, Thomsen MK, Hasenfuss SC, Wagner EF. Liver carcinogenesis by FOS-dependent inflammation and cholesterol dysregulation. J Exp Med. 2017;214(5):1387\u20131409. doi: 10.1084/jem.20160935.", "ArticleIdList": ["10.1084/jem.20160935", "PMC5413325", "28356389"]}, {"Citation": "Yang XJ, Liu F, Feng N, Ding XS, Chen Y, Zhu SX, Yang LC, Feng XF. Berberine attenuates cholesterol accumulation in macrophage foam cells by suppressing AP-1 activity and activation of the Nrf2/HO-1 pathway. J Cardiovasc Pharmacol. 2020;75(1):45\u201353. doi: 10.1097/FJC.0000000000000769.", "ArticleIdList": ["10.1097/FJC.0000000000000769", "31895879"]}, {"Citation": "Liu Z, Wang J, Huang E, Gao S, Li H, Lu J, Tian K, Little PJ, Shen X, Xu S, Liu P. Tanshinone IIA suppresses cholesterol accumulation in human macrophages: role of heme oxygenase-1. J Lipid Res. 2014;55(2):201\u2013213. doi: 10.1194/jlr.M040394.", "ArticleIdList": ["10.1194/jlr.M040394", "PMC3886659", "24302760"]}, {"Citation": "O'Hare EA, Wang X, Montasser ME, Chang YP, Mitchell BD, Zaghloul NA. Disruption of ldlr causes increased LDL-c and vascular lipid accumulation in a zebrafish model of hypercholesterolemia. J Lipid Res. 2014;55(11):2242\u20132253. doi: 10.1194/jlr.M046540.", "ArticleIdList": ["10.1194/jlr.M046540", "PMC4617127", "25201834"]}, {"Citation": "Bhasker CR, Friedmann T. Insulin-like growth factor-1 coordinately induces the expression of fatty acid and cholesterol biosynthetic genes in murine C2C12 myoblasts. BMC Genomics. 2008;9(1):535. doi: 10.1186/1471-2164-9-535.", "ArticleIdList": ["10.1186/1471-2164-9-535", "PMC2628395", "19014463"]}, {"Citation": "Mendoza MC, Er EE, Blenis J. The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation. Trends Biochem Sci. 2011;36(6):320\u2013328. doi: 10.1016/j.tibs.2011.03.006.", "ArticleIdList": ["10.1016/j.tibs.2011.03.006", "PMC3112285", "21531565"]}, {"Citation": "Bakan I, Laplante M. Connecting mTORC1 signaling to SREBP-1 activation. Curr Opin Lipidol. 2012;23(3):226\u2013234. doi: 10.1097/MOL.0b013e328352dd03.", "ArticleIdList": ["10.1097/MOL.0b013e328352dd03", "22449814"]}, {"Citation": "Mukhopadhyay S, Saqcena M, Chatterjee A, Garcia A, Frias MA, Foster DA. Reciprocal regulation of AMP-activated protein kinase and phospholipase D. J Biol Chem. 2015;290(11):6986\u20136993. doi: 10.1074/jbc.M114.622571.", "ArticleIdList": ["10.1074/jbc.M114.622571", "PMC4358122", "25632961"]}, {"Citation": "Motoshima H, Goldstein BJ, Igata M, Araki E. AMPK and cell proliferation--AMPK as a therapeutic target for atherosclerosis and cancer. J Physiol. 2006;574(Pt 1):63\u201371. doi: 10.1113/jphysiol.2006.108324.", "ArticleIdList": ["10.1113/jphysiol.2006.108324", "PMC1817805", "16613876"]}, {"Citation": "Yue J, L\u00f3pez JM. Understanding MAPK signaling pathways in apoptosis. Int J Mol Sci. 2020;21(7):2346. doi: 10.3390/ijms21072346.", "ArticleIdList": ["10.3390/ijms21072346", "PMC7177758", "32231094"]}, {"Citation": "Ameyar M, Wisniewska M, Weitzman JB. A role for AP-1 in apoptosis: the case for and against. Biochimie. 2003;85(8):747\u2013752. doi: 10.1016/j.biochi.2003.09.006.", "ArticleIdList": ["10.1016/j.biochi.2003.09.006", "14585541"]}, {"Citation": "Brenner D, Blaser H, Mak TW. Regulation of tumour necrosis factor signalling: live or let die. Nat Rev Immunol. 2015;15(6):362\u2013374. doi: 10.1038/nri3834.", "ArticleIdList": ["10.1038/nri3834", "26008591"]}, {"Citation": "Mukhopadhyay S, Vander Heiden MG, McCormick F. The metabolic landscape of RAS-driven cancers from biology to therapy. Nat Can. 2021;2(3):271\u2013283. doi: 10.1038/s43018-021-00184-x.", "ArticleIdList": ["10.1038/s43018-021-00184-x", "PMC8045781", "33870211"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "3", "Day": "11"}, {"Year": "2021", "Month": "5", "Day": "24"}, {"Year": "2021", "Month": "6", "Day": "10", "Hour": "5", "Minute": "38"}, {"Year": "2021", "Month": "6", "Day": "11", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "11", "Day": "3", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "6", "Day": "9"}], "PublicationStatus": "epublish", "ArticleIdList": ["34107900", "PMC8191108", "10.1186/s12885-021-08402-6", "10.1186/s12885-021-08402-6"]}}], "PubmedBookArticle": []}